Extramammary Paget's disease: Analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein

Human Pathology

Volumn 36, Issue 12, 2005, Pages 1273-1280

  Ogawa, Toru ^a   Nagashima, Yoji ^a   Wada, Hidefumi ^a   Akimoto, Kazunori ^a   Chiba, Yoshiyuki ^a   Nagatani, Tetsuo ^a   Inayama, Yoshiaki ^b   Yao, Masahiro ^a   Aoki, Ichiro ^a   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

(Phosphorylated) AKT; (Phosphorylated) ERK; (Phosphorylated) human epidermal growth factor receptor 2; Extramammary Paget's disease; Ki 67

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PAGET SKIN DISEASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; CHROMOGENIC COMPOUNDS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PAGET'S DISEASE, EXTRAMAMMARY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 27944432486     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.09.009     Document Type: Article

References (35)

1. W. Dubreuilh Paget's disease of the vulva Br J Dermatol 13 1901 407 413
2. C.I. Bargmann, M.-C. Hung, and R.A. Weinberg The neu oncogene encodes an epidermal growth factor receptor-related protein Nature 319 1986 226 230
3. D.J. Slamon, W. Godolphin, and L.A. Jones Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
4. M. Dorset, J. Bartlett, and I.O. Ellis Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centers J Pathol 199 2003 418 423
5. D.J. Slamon, B. Leyland-Jones, and S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
6. C.L. Vogel, and S.X. Franco Clinical experience with trastuzumab (Herceptin) Breast J 9 2003 452 462
7. B. Leyland-Jones, K. Gelmon, and J.-P. Ayoub Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel J Clin Oncol 21 2003 3965 3971
8. K. Meissner, A. Riviere, G. Haupt, and T. Loning Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease Am J Pathol 137 1990 1305 1309
9. R.A. Wolber, B.A. Dupuis, and M.R. Wick Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease Am J Clin Pathol 96 1991 243 247
10. L. Keatings, J. Sinclair, and C. Wright c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study Histopathology 17 1990 243 247
11. G.A. Lammie, D.M. Barnes, R.R. Millis, and W.J. Gullick An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease Histopathology 15 1989 505 514
12. W. Fu, C.A. Lobocki, and B.K. Silberberg Molecular markers in Paget's disease of the breast J Surg Oncol 77 2001 171 180
13. M. Tanskanen, T. Jahkola, S. Asko-Seljavaara, J. Jalknen, and J. Isola HER2 oncogene amplification in extramammary Paget's disease Histopathology 42 2003 575 579
14. M. Tanner, D. Gancberg, and A. Di Leo Chromogenic in situ hybridization. A practical alternative for fluorescence in situ hybridization to detect HER2/neu oncogene amplification in archival breast cancer samples Am J Pathol 157 2000 1467 1472
15. T.W. Jacobes, A.M. Gown, H. Yaziji, M.J. Barnes, and S.J. Schnitt Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system J Clin Oncol 17 1999 1983 1987
16. A. Taki, Y. Nakatani, K. Misugi, M. Yao, and Y. Nagashima Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese case Mod Pathol 12 1999 310 317
17. K.J. Schnitz, F. Otterbach, and R. Callis Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases Mod Pathol 17 2004 15 21
18. P.E. Ellis, L.F. Fong, and K.J. Rolfe The role of p53 and Ki67 in Paget's disease of the vulva and the breast Gynecol Oncol 86 2002 150 156
19. J.R. Testa, and A. Bellacosa AKT plays a central role in tumorigenesis Proc Natl Acad Sci U S A 98 2001 10983 10985
20. M. Sun, G. Wang, and J.E. Paciga AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells Am J Pathol 159 2001 431 437
21. B. Alfonso, D.F. Daniela, and K.G. Andrew Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas Int J Cancer 64 1995 280 285
22. S.K. Muthuswany, M. Gilman, and J.S. Brugge Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers Mol Cell Biol 19 1999 6845 6857
23. S.S. Bacus, D.A. Altomare, and L. Lyass AKT is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival Oncogene 21 2002 3532 3540
24. G. Perez-Tenorio, O. Stal Members of the Southeast Sweden Breast Cancer Group Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients Br J Cancer 86 2002 540 545
25. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev 13 1999 2905 2927
26. M.H. Cardone, N. Roy, and H.R. Stennicke Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318 1321
27. B.P. Zhou, Y. Liao, W. Xia, B. Spohn, M.H. Lee, and M.C. Hung Cytoplasmic localization of p21 Cip1/WAF1 by Akt-induced phosphorylation in HER2/neu-overexpressing cells Nat Cell Biol 3 2001 245 252
28. I. Shin, F.M. Yakes, and F. Rojo PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization Nat Med 8 2002 1145 1152
29. X. Sastre-Garau, P. Genin, and A. Rousseau Increased cell size and Akt activation in HER2/neu-overexpressing invasive ductal carcinoma of the breast Histopathology 45 2004 142 147
30. M.J. Robinson, and M.H. Cobb Mitogen-activated protein kinase pathways Curr Opin Cell Biol 9 1997 180 186
31. H. Mueller, N. Flury, S. Eppenberger-Castoli, W. Kueng, F. David, and U. Eppenberger Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients Int J Cancer 89 2000 384 388
32. V.S. Sivaraman, H. Wang, G.J. Nuovo, and C.C. Malbon Hyperexpression of mitogen-activated protein kinase in human breast cancer J Clin Invest 79 1997 1478 1483
33. K.J. Schmitz, F. Otterbach, and R. Callies Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases Mod Pathol 17 2004 15 21
34. M. Takata, A. Fujimoto, H. Aoki, N. Hatta, A. Ooi, and K. Takehara erb-2 overexpression but no activation of β-catenin gene in extramammary Paget's disease J Invest Dermatol 113 1999 258 262
35. O. Reich, B. Liegl, K. Tamussino, and S. Regauer p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease Mod Pathol 18 2005 354 357